Synthetic pentadecapeptide (research)
BPC-157
$49.00
Category
Tissue-repair research peptides including BPC-157 and thymosin beta-4 fragments, studied in vitro for cytoprotection, actin-binding and angiogenesis pathways. Sequence-verified, ≥99% HPLC, CoA per lot. Research use only.
2 products
Peptides in this group — including BPC-157 and thymosin beta-4 fragments — are studied in vitro for cytoprotection, actin-binding, and angiogenesis-related pathways. BluGen supplies them as lyophilized RUO materials with lot-specific CoA documentation.
Do not interpret preclinical literature as evidence for human or veterinary outcomes. These listings exist to support documented laboratory research programs only.
For pentadecapeptide and thymosin-fragment SKUs, confirm sequence, observed MS mass, HPLC purity, and net peptide content on the lot certificate. See our guide on quality testing for acceptance criteria (≥98% release floor; most lots ≥99%).
Confirm sequence and observed MS mass on the lot CoA, plus HPLC purity and net peptide content, before releasing material into a study inventory.
No. All listings are research-use-only (RUO) for qualified laboratory and institutional research programs. Not for human or veterinary use.
Each released lot includes a certificate of analysis reporting HPLC purity, MS identity, net peptide content, water content, and residual solvents where applicable. Verify lots in the CoA Library.
Yes. Academic labs, CROs, and qualified institutions can request quotes and NET-30 billing after vendor qualification. See the institutions hub or contact procurement.
RUO guides and comparisons for compounds in this group — for laboratory procurement and QA review.
Researcher verification
BluGen sells research-grade peptides exclusively to qualified researchers and laboratories for in-vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic or therapeutic procedures, and have not been evaluated by the U.S. Food and Drug Administration.